Andrew Lynn Sprague, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 540 S College Ave, Newark, DE 19713 Phone: 302-831-7422 |
Dr. Jessica Elizabeth Galgiani, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 540 S College Ave, Newark, DE 19713 Phone: 302-831-8910 |
Angela Crouch Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Hygeia Dr, Pt Plus, Newark, DE 19713 Phone: 302-623-0390 Fax: 302-623-0393 |
Mr. Brian Patrick Matson, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Hygeia Dr, Newark, DE 19713 Phone: 302-623-0390 Fax: 302-623-0393 |
Shannon Burke Colleton, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 540 S College Ave Ste 160, Newark, DE 19713 Phone: 302-831-8893 Fax: 302-831-4468 |
News Archive
Itamar Medical announced confirmation of PAT technology by several prestigious research groups. In light of scientific confirmation of PAT technology, Itamar Medical will now promote clinical use in the medical community for the prevention of cardiovascular disease.
Paula Meltzer was only 38 when out of nowhere everything she looked at was blurry. For the single mother, who had a lucrative career as a gemologist and spent hours examining valuable pieces of jewelry, it seemed as if - in a split second - her life changed.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Jennifer James, founder of Mom Bloggers for Social Good, discusses how social media is advancing the conversation surrounding global newborn health.
The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded more than $1.4 million from the National Cancer Institute of the National Institutes of Health to create a potential new drug to attack the malignant cells that cause chronic lymphocytic leukemia (CLL), which is the most common leukemia in the Western world.
› Verified 4 days ago